Dr. Jekyll and Mr. Hyde: ApoE explains opposing effects of neuronal LRP1

Por Strickland, Michael R., Holtzman, David M.
Publicado no J Clin Invest (2019)

Ifngr1 and Stat1 mediated canonical Ifn-γ signaling drives nigrostriatal degeneration

Por Strickland, Michael R, Koller, Emily J, Deng, Doris Z, Ceballos-Diaz, Carolina, Golde, Todd E, Chakrabarty, Paramita
Publicado no Neurobiol Dis (2017)

Microglia-specific targeting by novel capsid-modified AAV6 vectors

Por Rosario, Awilda M, Cruz, Pedro E, Ceballos-Diaz, Carolina, Strickland, Michael R, Siemienski, Zoe, Pardo, Meghan, Schob, Keri-Lyn, Li, Andrew, Aslanidi, George V, Srivastava, Arun, Golde, Todd E, Chakrabarty, Paramita
Publicado no Mol Ther Methods Clin Dev (2016)

TLR5 decoy receptor as a novel anti-amyloid therapeutic for Alzheimer’s disease

Por Chakrabarty, Paramita, Li, Andrew, Ladd, Thomas B., Strickland, Michael R., Koller, Emily J., Burgess, Jeremy D., Funk, Cory C., Cruz, Pedro E., Allen, Mariet, Yaroshenko, Mariya, Wang, Xue, Younkin, Curtis, Reddy, Joseph, Lohrer, Benjamin, Mehrke, Leonie, Moore, Brenda D., Liu, Xuefei, Ceballos-Diaz, Carolina, Rosario, Awilda M., Medway, Christopher, Janus, Christopher, Li, Hong-Dong, Dickson, Dennis W., Giasson, Benoit I., Price, Nathan D., Younkin, Steven G., Ertekin-Taner, Nilüfer, Golde, Todd E.
Publicado no J Exp Med (2018)